Whitehawk Therapeutics (WHWK)

Profile

Full Name

Whitehawk Therapeutics, Inc.

Ticker Symbol

WHWK

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

August 1, 2017

Indexes

Not included

Website

http://ir.whitehawktx.com

Employees

40

Key Details

Price

$1.64(+1.23%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$25.98M(+6.69% YoY)

Annual EPS

-$2.36(+3.28% YoY)

PE ratio

-

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.64
WHWK price is $1.64

30-Day Relative Volume

0.84
WHWK 30-day relative volume is 0.84

Price Performance

Price Most recent change

+1.23%
WHWK price was up +1.23% on Apr 11, 2025

Price YTD change

-48.02%
WHWK price is down -48.02% since January 1st

Price 1-year change

-17.59%
WHWK price is down -17.59% year-on-year

Price 3-year change

-90.02%
WHWK price is down -90.02% over the past 3 years

Price Range

Price All-time high

$78.00
WHWK price is currently -97.90% below its historical high of $78.00

Price 3-year low

$1.21
WHWK price is currently +35.54% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$76.73M
WHWK market capitalization is $76.73 million

Market cap 3-year change

-77.71%
WHWK market capitalization is down -77.71% over the past 3 years

Market cap All-time high

$681.59M
WHWK market capitalization is currently -88.74% below its historical high of $681.59 million

Market cap sector rank

45.03%
WHWK market capitalization is higher than 45.03% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+90.54%
WHWK shares outstanding is up +90.54% year-on-year

Shares Outstanding 3-Year Change

+123.4%
WHWK shares outstanding is up +123.4% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.83
WHWK beta is 0.83

200-day SMA

$2.12
WHWK price is currently -22.76% below its 200-day simple moving average

50-day SMA

$2.23
WHWK price is currently -26.55% below its 50-day simple moving average

RSI

31.09
WHWK 14-day relative strength index is 31.09

Volume

0.84
WHWK 30-day relative volume is 0.84

ATR

$0.15
WHWK average true range is $0.15

10-day Historical Volatility

53.42%
WHWK 10-day historical volatility is 53.42%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$25.98M
WHWK annual revenue is $25.98 million

Revenue Analysts estimate

$50.00M
WHWK annual revenue is currently -48.03% lower than the consensus analysts' forecast

Revenue 1-year change

+6.69%
WHWK annual revenue is up +6.69% year-on-year

Revenue Sector rank

-
WHWK annual revenue is unknown

EPS

EPS

-$2.36
WHWK annual earnings per share is -$2.36

EPS Analysts estimate

-
WHWK annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+3.28%
WHWK annual earnings per share is up +3.28% year-on-year

EPS Sector rank

-
WHWK annual earnings per share is unknown

Profit

Gross profit

$22.96M
WHWK annual gross profit is $22.96 million

Gross margin

88.36%
WHWK annual gross profit margin is 88.36%

Operating profit

-$64.82M
WHWK annual operating income is -$64.82 million

Operating margin

-249.47%
WHWK annual operating profit margin is -249.47%

Net income

-$63.69M
WHWK annual net profit is -$63.69 million

Net margin

-245.13%
WHWK annual net profit margin is -245.13%

Expenses

Total expenses

$90.80M
WHWK annual total expenses is $90.80 million

Operating expenses

$87.78M
WHWK annual total operating expenses is $87.78 million

Cost of goods sold

$3.02M
WHWK annual cost of goods sold is $3.02 million

Selling, general & administrative expenses

$36.75M
WHWK annual SGA is $36.75 million

Depreciation and amortization

$193.00K
WHWK annual depreciation & amortization is $193.00 thousand

Interest expense

$154.00K
WHWK annual interest expense is $154.00 thousand

Income tax

$0.00
WHWK annual income tax is $0.00

EBIT & EBITDA

EBIT

-$63.54M
WHWK annual earnings before interest & taxes is -$63.54 million

EBITDA

-$63.54M
WHWK annual EBITDA is -$63.54 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$70.32M
WHWK annual total assets is $70.32 million

Non current assets

$9.03M
WHWK annual long term assets is $9.03 million

Current assets

$61.29M
WHWK annual total current assets is $61.29 million

Cash and cash equivalents

$28.67M
WHWK annual cash & cash equivalents is $28.67 million

Accounts receivable

$5.90M
WHWK annual accounts receivable is $5.90 million

Inventory

$5.31M
WHWK annual inventory is $5.31 million

Liabilities

Total liabilities

$17.84M
WHWK annual total liabilities is $17.84 million

Long term liabilities

$767.00K
WHWK annual total long term liabilities is $767.00 thousand

Current liabilities

$17.07M
WHWK annual total current liabilities is $17.07 million

Accounts payable

$2.16M
WHWK annual accounts payable is $2.16 million

Debt

Total debt

$833.00K
WHWK annual total debt is $833.00 thousand

Total debt 1-year change

-34.25%
WHWK annual total debt is down -34.25% year-on-year

Long term debt

$565.00K
WHWK annual long term debt is $565.00 thousand

Short term debt

$268.00K
WHWK annual short term debt is $268.00 thousand

Equity & Capital

Shareholders equity

$52.48M
WHWK annual stockholders equity is $52.48 million

Book value

$52.48M
WHWK annual book value is $52.48 million

Retained earnings

-$332.65M
WHWK annual retained earnings is -$332.65 million

Working capital

$44.21M
WHWK annual working capital is $44.21 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$59.55M
WHWK annual cash flow from operations is -$59.55 million

Cash from operations 1-year change

+0.19%
WHWK annual cash flow from operations is up +0.19% year-on-year

Cash from investing

$25.20M
WHWK annual cash flow from investing activities is $25.20 million

Cash from investing 1-year change

-69.71%
WHWK annual cash flow from investing activities is down -69.71% year-on-year

Cash from financing

$130.00K
WHWK annual cash flow from financing activities is $130.00 thousand

Cash from financing 1-year change

-60.12%
WHWK annual cash flow from financing activities is down -60.12% year-on-year

CAPEX

CAPEX

$1.65M
WHWK annual capital expenditures is $1.65 million

CAPEX 1-year change

-58.36%
WHWK annual capital expenditures is down -58.36% year-on-year

Free Cash Flow

Free cash flow

-$61.20M
WHWK annual free cash flow is -$61.20 million

Free cash flow 1-year change

+3.82%
WHWK annual free cash flow is up +3.82% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

88.36%
WHWK annual gross profit margin is 88.36%

Operating margin

-249.47%
WHWK annual operating profit margin is -249.47%

Net margin

-245.13%
WHWK annual net profit margin is -245.13%

ROA & ROE

ROA

-62.83%
WHWK annual return on assets is -62.83%

ROE

-80.79%
WHWK annual return on equity is -80.79%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
WHWK price to earnings ratio value is unknown

PE ratio Sector rank

-
WHWK price to earnings ratio is unknown

PB Ratio

PB ratio

1.46
WHWK price to book ratio is 1.46

PB ratio Sector rank

54.77%
WHWK price to book ratio is higher than 54.77% of companies in Healthcare sector

PS Ratio

PS ratio

2.95
WHWK price to sales ratio is 2.95

PS ratio Sector rank

51.54%
WHWK price to sales ratio is higher than 51.54% of companies in Healthcare sector

Enterprise value

Enterprise value

$48.89M
WHWK enterprise value is $48.89 million

Enterprise value Sector rank

42.21%
WHWK enterprise value is higher than 42.21% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.77
WHWK EV/EBITDA is -0.77

EV/EBITDA Sector rank

46.79%
WHWK EV/EBITDA is higher than 46.79% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

3.59
WHWK annual current ratio is 3.59

Quick ratio

3.28
WHWK annual quick ratio is 3.28

Leverage

Debt to equity

0.00
WHWK annual debt to equity ratio is 0.00

Interest coverage ratio

-412.58
WHWK annual interest coverage ratio is -412.58

Risk & Stability

Piotroski F-Score

4
WHWK piotroski f-score is 4

Altman Z-Score

-5.90
WHWK altman z-score is -5.90

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

ENTX logo
Entera Bio (ENTX)
SY logo
So-Young International (SY)
FONR logo
FONAR (FONR)
SRZN logo
Surrozen (SRZN)
AVTE logo
Aerovate Therapeutics (AVTE)
XGN logo
Exagen (XGN)
BDSX logo
Biodesix (BDSX)
SRTS logo
Sensus Healthcare (SRTS)
NSPR logo
InspireMD (NSPR)
  • What is the ticker symbol for Whitehawk Therapeutics?
  • Does Whitehawk Therapeutics pay dividends?
  • What sector is Whitehawk Therapeutics in?
  • What industry is Whitehawk Therapeutics in?
  • What country is Whitehawk Therapeutics based in?
  • When did Whitehawk Therapeutics go public?
  • Is Whitehawk Therapeutics in the S&P 500?
  • Is Whitehawk Therapeutics in the NASDAQ 100?
  • Is Whitehawk Therapeutics in the Dow Jones?
  • When was Whitehawk Therapeutics's last earnings report?
  • When does Whitehawk Therapeutics report earnings?
  • Should I buy Whitehawk Therapeutics stock now?

What is the ticker symbol for Whitehawk Therapeutics?

The ticker symbol for Whitehawk Therapeutics is NASDAQ:WHWK

Does Whitehawk Therapeutics pay dividends?

No, Whitehawk Therapeutics does not pay dividends

What sector is Whitehawk Therapeutics in?

Whitehawk Therapeutics is in the Healthcare sector

What industry is Whitehawk Therapeutics in?

Whitehawk Therapeutics is in the Biotechnology industry

What country is Whitehawk Therapeutics based in?

Whitehawk Therapeutics is headquartered in United States

When did Whitehawk Therapeutics go public?

Whitehawk Therapeutics's initial public offering (IPO) was on August 1, 2017

Is Whitehawk Therapeutics in the S&P 500?

No, Whitehawk Therapeutics is not included in the S&P 500 index

Is Whitehawk Therapeutics in the NASDAQ 100?

No, Whitehawk Therapeutics is not included in the NASDAQ 100 index

Is Whitehawk Therapeutics in the Dow Jones?

No, Whitehawk Therapeutics is not included in the Dow Jones index

When was Whitehawk Therapeutics's last earnings report?

Whitehawk Therapeutics's most recent earnings report was on Mar 19, 2025

When does Whitehawk Therapeutics report earnings?

The next expected earnings date for Whitehawk Therapeutics is May 8, 2025

Should I buy Whitehawk Therapeutics stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page